{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:52:27Z","timestamp":1762145547184,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.mehy.2020.110011","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T09:18:53Z","timestamp":1592644733000},"page":"110011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19"],"prefix":"10.1016","volume":"144","author":[{"given":"NandhaKumar","family":"Sathyamoorthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavan Kumar","family":"Chintamaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhivardhan","family":"Chinni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.110011_b0005","doi-asserted-by":"crossref","first-page":"2000058","DOI":"10.2807\/1560-7917.ES.2020.25.4.2000058","article-title":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020","volume":"25","author":"Riou","year":"2020","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.mehy.2020.110011_b0010","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/ijmr.IJMR_761_20","article-title":"Responding to COVID-19 pandemic: Why a strong health system is required","volume":"151","author":"Dikid","year":"2020","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.mehy.2020.110011_b0015","series-title":"International journal of antimicrobial agents","first-page":"105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges","author":"Lai","year":"2020"},{"key":"10.1016\/j.mehy.2020.110011_b0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/d41587-020-00003-1","article-title":"Coronavirus puts drug repurposing on the fast track","volume":"38","author":"Harrison","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.mehy.2020.110011_b0025","article-title":"FDA approved drugs with broad anti-coronaviral activity inhibit SARS-CoV-2 in vitro","author":"Weston","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.mehy.2020.110011_b0030","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.123.5.1107","article-title":"Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation","volume":"123","author":"Wang","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.mehy.2020.110011_b0035","article-title":"Teicoplanin potently blocks the cell entry of 2019-nCoV","author":"Zhang","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.mehy.2020.110011_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105944","article-title":"Teicoplanin: an alternative drug for the treatment of coronavirus COVID-19","author":"Baron","year":"2020","journal-title":"Int J Antimicrob Agents"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720313360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720313360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:27:15Z","timestamp":1759692435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720313360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":8,"alternative-id":["S0306987720313360"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110011","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plausible role of combination of Chlorpromazine hydrochloride and Teicoplanin against COVID-19","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110011"}}